Skip to content
value.today

Frontier Medicines Corp

Total raised
$156 M
2 rounds on record
Latest round
$89 M
Jun 2021
First round on record
Apr 2019
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Frontier Medicines Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2021$89 MNo. 2$50 to $250 million

Frontier Medicines Corp: Raise no. 2, Jun 2021

Investors in this round

17 investors had bought by the notice of Jul 12, 2021: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$89 M of $89 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Varma, Ph.D. · Executive Officer, Director
  • Gregory Chow · Executive Officer
  • Jim Winkler · Executive Officer
  • Johannes Hermann, Ph.D. · Executive Officer
  • Kevin Webster · Executive Officer
  • Cameron Wheeler · Director
  • Janwillem Naesens · Director
  • Luke Evnin · Director
  • Othman Laraki · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Varma, Ph.D., Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 12, 2021. Read the notice at the SEC.

equitySEC
Apr 2019$67 MNo. 1$50 to $250 million

Frontier Medicines Corp: Raise no. 1, Apr 2019

Investors in this round

31 investors had bought by the notice of Nov 6, 2020: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$67 M of $67 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Chris Varma, Ph.D. · Executive Officer, Director
  • Jim Winkler · Executive Officer
  • Johannes Hermann, Ph.D. · Executive Officer
  • Kevin Webster · Executive Officer
  • Cameron Wheeler · Director
  • Janwillem Naesens · Director
  • Luke Evnin · Director
  • Othman Laraki · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Varma, Ph.D., Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Nov 6, 2020. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Frontier Medicines Corp chose not to state its revenue in its newest notice of a funding round (Jul 2021).

    SEC Form D · Jul 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2021

That is all the official record says: Frontier Medicines Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Frontier Medicines Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 31 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Frontier Medicines Corp
NameRoleNamed in
Chris Varma, Ph.D.Executive officerJul 2021
Gregory ChowExecutive officerJul 2021
Jim WinklerExecutive officerJul 2021
Johannes Hermann, Ph.D.Executive officerJul 2021
Kevin WebsterExecutive officerJul 2021
Cameron WheelerDirectorJul 2021
Chris Varma, Ph.D.DirectorJul 2021
Janwillem NaesensDirectorJul 2021
Luke EvninDirectorJul 2021
Othman LarakiDirectorJul 2021